Clinical Trials
BrainPort Balance
Wicab is sponsoring clinical studies* at various medical centers in the U.S. and Europe to evaluate the effectiveness of the BrainPort balance device for improving balance in people with balance difficulties. Additional studies are being planned. Please contact Wicab if you would like information about clinical trial participation.
Peripheral Vestibular Dysfunction Controlled Study
Subjects enrolled in the current multi-site peripheral vestibular dysfunction study must meet all of the following criteria:
- Male or female, age 18-79 years old.
- Documented diagnosis of unilateral vestibular hypofunction or bilateral vestibular hypofunction confirmed by vestibular function testing (Caloric testing or Rotary Chair testing) for at least 3 months.
- Previously treated with conventional physical therapy, and discharged and/or reached a plateau.
- Ability to stand independently for 2 minutes with minimal upper extremity support.
- Dynamic Gait Index <20/24 (Testing is completed at the study site).
- No history of seizures or epilepsy.
- No implanted electrical medical device (i.e. pacemaker, deep brain stimulator).
To view a list of clinics participating in this study, click here.
Stroke Study
Subjects enrolled in the current stroke/brain injury study must meet all of the following criteria:
- Male or female, at least 18 years old.
- Documented history of stroke for a duration of at least 6 months which has been treated with conventional therapy
- Have reached a plateau and been discharged from physical therapy.
- Able to ambulate with assistance.
- Dynamic Gait Index score of <22/24 and/or Berg Balance Scale score of <45/56.
- Able to read and understand the informed consent form, and willing to sign the informed consent form.
- Willing to complete all follow-up evaluations required by the study protocol.
* The clinical studies referenced are conducted under Institutional Review Board approved protocols and with patient consents.
The BrainPort balance device is an Investigational Device and its use remains limited by U.S. Federal Law to investigational uses only. WICAB MAKES NO REPRESENTATIONS REGARDING THE DEVICE SAFETY OR EFFICACY.